Invenomic Capital Management LP - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invenomic Capital Management LP ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2022$276,000
-64.1%
43,560
-67.9%
0.02%
-75.6%
Q1 2022$769,000
-12.4%
135,631
+7.2%
0.08%
-56.4%
Q4 2021$878,000
-17.6%
126,477
+0.9%
0.19%
-45.7%
Q3 2021$1,065,000
+37.1%
125,315
+12.2%
0.35%
+86.0%
Q2 2021$777,000
+11.2%
111,654
-1.0%
0.19%
+19.2%
Q1 2021$699,000
+2.8%
112,767
-15.6%
0.16%
-9.8%
Q4 2020$680,000
+52.5%
133,613
+32.2%
0.17%
-29.7%
Q3 2020$446,000
+3.7%
101,084
+29.5%
0.25%
-22.6%
Q2 2020$430,00078,0640.32%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders